YUN; Chang Soo

Patent Applications and Registrations

Patent applications and USPTO patent grants for YUN; Chang Soo.The latest application filed is for "target protein eed degradation-inducing degraducer, preparation method thereof, and pharmaceutical composition for preventing or treating diseases related to eed, ezh2, or prc2, comprising same as active ingredient".

Company Profile

4.7.9

YUN; Chang Soo - Daejeon KR
YUN; Chang Soo - Seongnam KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Target Protein Eed Degradation-inducing Degraducer, Preparation Method Thereof, And Pharmaceutical Composition For Preventing Or Treating Diseases Related To Eed, Ezh2, Or Prc2, Comprising Same As Active Ingredient App 20220105188 - HWANG; Jong Yeon ; et al.	2022-04-07
Piperidine-2,6-dione derivative and use thereof Grant 11,192,878 - Hwang , et al. December 7, 2	2021-12-07
Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient Grant 11,084,824 - Kim , et al. August 10, 2	2021-08-10
Pyrazolopyrimidine Derivatives, Preparation Method Thereof, And Pharmaceutical Composition For Use In Preventing Or Treating Can App 20200199129 - Kim; Pilho ; et al.	2020-06-25
Novel Piperidine-2,6-dione Derivative And Use Thereof App 20200062730 - HWANG; Jong Yeon ; et al.	2020-02-27
4-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredient Grant 10,369,149 - Hwang , et al.	2019-08-06
N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient Grant 10,100,019 - Kim , et al. October 16, 2	2018-10-16
Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient Grant 10,053,458 - Yun , et al. August 21, 2	2018-08-21
Shoe Enabling Attachment/detachment Of Decoration App 20180213881 - YUN; Chang Soo	2018-08-02
N2-(2-methoxyphenyl)pyrimidine Derivative, Method For Preparing Same, And Pharmaceutical Composition For Cancer Prevention Or Treatment Containing Same As Active Ingredient App 20180111905 - Kim; Pilho ; et al.	2018-04-26
4-(2-amino-tetrahydronaphthalenyl)pyrimidine Derivative, Preparation Method Therefor, And Pharmaceutical Composition For Preventing Or Treating Cancer, Containing Same As Active Ingredient App 20180104242 - HWANG; Jong Yeon ; et al.	2018-04-19
Pyrimidine-2,4-diamine Derivative And Anticancer Pharmaceutical Composition Comprising Same As Effective Ingredient App 20170145007 - YUN; Chang Soo ; et al.	2017-05-25
Antiviral pyrrolopyridine derivatives and method for preparing the same Grant 9,499,537 - Son , et al. November 22, 2	2016-11-22
2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient Grant 9,266,872 - Kim , et al. February 23, 2	2016-02-23
Novel Antiviral Pyrrolopyridine Derivatives And Method For Preparing The Same App 20140249162 - SON; Jong Chan ; et al.	2014-09-04
2-hydroxyarylamide Derivative Or Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, And Pharmaceutical Composition For Preventing Or Treating Cancer Containing Same As Active Ingredient App 20140221411 - KIM; Semi ; et al.	2014-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.